SK13552001A3 - Tienopyrimidíny, spôsob ich výroby a použitie - Google Patents

Tienopyrimidíny, spôsob ich výroby a použitie Download PDF

Info

Publication number
SK13552001A3
SK13552001A3 SK1355-2001A SK13552001A SK13552001A3 SK 13552001 A3 SK13552001 A3 SK 13552001A3 SK 13552001 A SK13552001 A SK 13552001A SK 13552001 A3 SK13552001 A3 SK 13552001A3
Authority
SK
Slovakia
Prior art keywords
compound
group
salt
alkyl
alkoxy
Prior art date
Application number
SK1355-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Schuichi Furuya
Nobuhiro Suzuki
Nobuo Choh
Yoshi Nara
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Publication of SK13552001A3 publication Critical patent/SK13552001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK1355-2001A 1999-03-24 2000-03-23 Tienopyrimidíny, spôsob ich výroby a použitie SK13552001A3 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7937199 1999-03-24
JP2000018019 2000-01-25
PCT/JP2000/001777 WO2000056739A1 (en) 1999-03-24 2000-03-23 Thienopyrimidine compounds, their production and use

Publications (1)

Publication Number Publication Date
SK13552001A3 true SK13552001A3 (sk) 2002-03-05

Family

ID=26420391

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1355-2001A SK13552001A3 (sk) 1999-03-24 2000-03-23 Tienopyrimidíny, spôsob ich výroby a použitie

Country Status (28)

Country Link
US (1) US6340686B1 (es)
EP (1) EP1163244B1 (es)
JP (1) JP3240293B2 (es)
KR (2) KR100370981B1 (es)
CN (1) CN1349536A (es)
AR (1) AR023152A1 (es)
AT (1) ATE261449T1 (es)
AU (1) AU764019B2 (es)
BR (1) BR0009297A (es)
CA (1) CA2368108C (es)
CZ (1) CZ294747B6 (es)
DE (1) DE60008862T2 (es)
DK (1) DK1163244T3 (es)
ES (1) ES2212992T3 (es)
HK (1) HK1042495B (es)
HU (1) HUP0200550A3 (es)
ID (1) ID30393A (es)
IL (1) IL145549A (es)
MX (1) MXPA01009566A (es)
MY (1) MY124726A (es)
NO (1) NO20014603L (es)
NZ (1) NZ514737A (es)
OA (1) OA11920A (es)
PL (1) PL351202A1 (es)
PT (1) PT1163244E (es)
SK (1) SK13552001A3 (es)
TW (1) TWI225863B (es)
WO (1) WO2000056739A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
AU2001234188A1 (en) * 2000-02-29 2001-09-12 Takeda Chemical Industries Ltd. Processes for the production of thienopyrimidine derivatives
US20030134863A1 (en) * 2000-04-13 2003-07-17 Shuichi Furuya Preventives/remedies for alzheimer's disease
CA2407472A1 (en) * 2000-06-14 2002-10-23 Takeda Chemical Industries, Ltd. Sustained release compositions
WO2002024230A1 (fr) * 2000-09-22 2002-03-28 Takeda Chemical Industries, Ltd. Preparations solides
WO2002043766A1 (fr) * 2000-11-29 2002-06-06 Takeda Chemical Industries, Ltd. Compositions medicinales et leur procede de preparation
WO2002047722A1 (fr) * 2000-12-15 2002-06-20 Takeda Chemical Industries, Ltd. Compositions medicinales agoniste ou antagoniste de la gonadoliberine non peptidyl, methode de production et utilisation desdites compositions
US20040116522A1 (en) * 2001-03-30 2004-06-17 Yutaka Yamagata Medicinal solutions
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
EP1411941A2 (en) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
US6673796B2 (en) 2001-08-02 2004-01-06 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
EP1411945A1 (en) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists
EP1412363A1 (en) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists
US7569570B2 (en) * 2002-01-30 2009-08-04 Takeda Pharmaceutical Company Limited Thienopyrimidines, process for preparing the same and use thereof
EP1495768A4 (en) 2002-04-12 2007-12-05 Takeda Pharmaceutical AGENTS FOR PREVENTING / TREATING HEAT BURSTS
US7317010B2 (en) * 2002-08-21 2008-01-08 Astrazeneca Ab Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
AU2004207706B2 (en) 2003-01-29 2010-03-04 Takeda Pharmaceutical Company Limited Thienopyrimidine compounds and use thereof
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
WO2006044902A2 (en) * 2004-10-18 2006-04-27 Bwt Property, Inc. A solid-state lighting apparatus for navigational aids
CN101272806A (zh) * 2005-07-22 2008-09-24 武田药品工业株式会社 过早排卵抑制剂
US20110172249A1 (en) 2008-09-03 2011-07-14 Takeda Pharmaceutical Company Limted Method for improving absorbability of preparation, and preparation having improved absorbability
AU2013226661B2 (en) * 2012-02-28 2017-08-31 Tiumbio Co., Ltd Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same
DK3415517T3 (da) 2012-09-28 2022-05-30 Takeda Pharmaceuticals Co Krystallinsk form af 1-(4-1-(2,6-difluorbenzyl)-5-dimethylaminomethyl-3-(6- methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)-pyrimidin- 6yl)phenyl)-3-methoxyurea
FI3263110T3 (fi) * 2015-02-26 2023-07-25 Takeda Pharmaceuticals Co Tabletti, joka käsittää metoksiureajohdannaista ja mannitolipartikkeleita
EP3518932A2 (en) 2016-09-30 2019-08-07 Myovant Sciences GmbH Treatment of prostate cancer
CA3038879A1 (en) 2016-09-30 2018-04-05 Myovant Sciences Gmbh Methods of treating uterine fibroids and endometriosis
KR101973074B1 (ko) * 2018-11-30 2019-04-26 주식회사 티움바이오 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물
WO2021018105A1 (en) * 2019-07-29 2021-02-04 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidinedione compounds and uses thereof
CN111574534B (zh) * 2020-05-25 2021-06-04 东莞市东阳光新药研发有限公司 苯基取代的噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮类化合物及其用途
CN111925379B (zh) * 2020-07-31 2022-02-15 广东东阳光药业有限公司 含氮杂芳基取代的嘧啶二酮类化合物及其用途
CN111909168B (zh) * 2020-07-31 2022-02-01 广东东阳光药业有限公司 含氮杂环基取代的嘧啶二酮类化合物及其用途
CN113754679B (zh) * 2020-09-09 2023-04-07 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN112047957B (zh) * 2020-09-09 2022-02-01 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN113563363B (zh) * 2020-12-30 2022-06-28 上海博志研新药物技术有限公司 瑞卢戈利中间体、其制备方法及瑞卢戈利的制备方法
CN115260211B (zh) * 2021-04-29 2024-02-06 长春金赛药业有限责任公司 含噻吩稠环类衍生物、药物组合物及其制备方法和应用
CN113717149A (zh) * 2021-09-29 2021-11-30 成都伊诺达博医药科技有限公司 一种瑞卢戈利关键中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW449600B (en) * 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
UY23948A1 (es) * 1995-02-08 2001-10-25 Takeda Chemical Industries Ltd Derivados de anillos condensados de tiofeno su producción y uso.
US5627786A (en) * 1995-02-10 1997-05-06 Micron Quantum Devices, Inc. Parallel processing redundancy scheme for faster access times and lower die area
WO1996028405A1 (fr) * 1995-03-10 1996-09-19 Nitto Chemical Industry Co., Ltd. Procede de production de derives de 1,2-ethanediol

Also Published As

Publication number Publication date
KR100370981B1 (ko) 2003-02-06
ID30393A (id) 2001-11-29
CZ20013419A3 (cs) 2002-02-13
CZ294747B6 (cs) 2005-03-16
TWI225863B (en) 2005-01-01
HK1042495A1 (en) 2002-08-16
DE60008862D1 (de) 2004-04-15
CA2368108A1 (en) 2000-09-28
DE60008862T2 (de) 2005-01-27
OA11920A (en) 2006-04-12
CA2368108C (en) 2009-12-22
AR023152A1 (es) 2002-09-04
IL145549A (en) 2005-11-20
NO20014603L (no) 2001-11-26
PT1163244E (pt) 2004-07-30
KR100533483B1 (ko) 2005-12-05
WO2000056739A1 (en) 2000-09-28
EP1163244B1 (en) 2004-03-10
JP3240293B2 (ja) 2001-12-17
US6340686B1 (en) 2002-01-22
HUP0200550A3 (en) 2004-07-28
MXPA01009566A (es) 2002-05-14
NZ514737A (en) 2003-10-31
MY124726A (en) 2006-06-30
KR20010090430A (ko) 2001-10-18
IL145549A0 (en) 2002-06-30
JP2001278884A (ja) 2001-10-10
HUP0200550A2 (en) 2002-06-29
ES2212992T3 (es) 2004-08-16
NO20014603D0 (no) 2001-09-21
AU764019B2 (en) 2003-08-07
HK1042495B (zh) 2004-10-08
AU3326200A (en) 2000-10-09
BR0009297A (pt) 2001-12-18
CN1349536A (zh) 2002-05-15
KR20010015920A (ko) 2001-02-26
PL351202A1 (en) 2003-03-24
ATE261449T1 (de) 2004-03-15
DK1163244T3 (da) 2004-07-12
EP1163244A1 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
SK13552001A3 (sk) Tienopyrimidíny, spôsob ich výroby a použitie
PL214756B1 (pl) Zwiazki tienopirymidynowe, kompozycja farmaceutyczna zawierajaca te zwiazki oraz ich zastosowanie
JPH09169768A (ja) チエノピリミジン誘導体、その製造法および用途
WO2007013964A1 (en) Pyrazolo pyrimidines useful as aurora kinase inhibitors
US6297379B1 (en) Thienopyrimidine compounds, their production and use
US6262267B1 (en) Thienopyridine compound
US6329388B2 (en) Thienopyridine compounds, their production and use
JP4652520B2 (ja) チエノピリミジン化合物、その製造法および用途
US6297255B1 (en) Thienopyridine compounds, their production and use
US20220267347A1 (en) Substituted pyrimidinedione compounds and uses thereof
JP2002030087A (ja) チエノピリジン−５−カルボン酸エステル化合物、その製造法および用途
JP2003183284A (ja) 含窒素複素環化合物およびその用途
JP3028486B1 (ja) チエノピリジン誘導体、その製造法および用途
CZ20004706A3 (cs) Thienopyridinové sloučeniny, způsob jejich výroby a použití
ZA200006601B (en) Thienopyridine compounds, their production and use.
MXPA00011184A (es) Compuestos de tienopiridina, su produccion y uso